<DOC>
	<DOC>NCT02019875</DOC>
	<brief_summary>The purpose of this study is to determine whether changes in the activity of the enzyme CYP3A4 can change the Vitamin D and bone mineral homeostasis.</brief_summary>
	<brief_title>CYP3A4 Induction and Mineral Homeostasis</brief_title>
	<detailed_description>Healthy volunteers will receive one of six interventions for 14 days (determined by randomization):a). 200 mL of water once a day; b) rifampin 600 mg once a day; c) 200 mL of grapefruit juice once a day for 8 days plus rifampin 600 mg once a day for 14 days; d) clarithromycin 250 mg twice a day; f) clarithromycin 250 mg twice a day plus rifampin 600 mg once a day.</detailed_description>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Subjects with no history of significant medical conditions including cardiac, pulmonary, gastrointestinal, or renal disease, HIV, diabetes mellitus or Hepatitis B or C Subjects will be males or females 1860 years of age Subjects must read and understand English Subjects must be able to provide informed consent Subjects must be willing to avoid prescription medications, OTC drugs, dietary supplements and foods that are known to modulate CYP3A4 expression or activity Subjects must be willing to maintain a consistent consumption of calcium and Vitamin D during the study and maintain a daily logbook of their dietary consumption Women not currently pregnant or lactating. In addition, women participants of childbearing age must be willing to utilize a barrier method of birth control (sterilization will be acceptable) Subjects will have no known allergies to the study drugs to be used Subject's corrected QTc interval obtained by electrocardiogram will be ≤ 430 ms in men or ≤ 450 ms in women Subjects with any significant chronic medical condition, including cardiac, pulmonary, gastrointestinal, or renal disease, HIV, diabetes mellitus or Hepatitis B or C Subjects less than 18 or greater than 60 years of age Subjects unable to read and understand English Subjects unable to provide informed consent Subjects unable to avoid prescription medications, OTC drugs, dietary supplements and foods that are known to modulate CYP3A4 expression or activity Subjects not willing to maintain a consistent consumption of calcium and Vitamin D during the study and maintain a daily logbook of their dietary consumption Women who are pregnant or lactating and women participants of childbearing age not willing to utilize a barrier method of birth control (sterilization will be acceptable) Subjects with allergies to rifampin, clarithromycin or grapefruit juice Potential participants will be excluded if they are concurrently participating in another research study Subjects with corrected QTc interval &gt; 430 ms in men or &gt; 450 ms in women on electrocardiogram</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>CYP3A4</keyword>
	<keyword>Calcium</keyword>
</DOC>